Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
14.30
-0.24 (-1.65%)
Aug 7, 2026, 4:00 PM EDT - Market closed
Immunic Market Cap
Immunic has a market cap or net worth of $194.79 million as of August 10, 2026. Its market cap has increased by 107.57% in one year.
Market Cap
194.79M
Enterprise Value
8.58M
1-Year Change
107.57%
Ranking
Category
Stock Price
$14.30
ChartMarket Cap Chart
Since April 15, 2019, Immunic's market cap has decreased from $243.61M to $194.79M, a decrease of -20.04%. That is a compound annual growth rate of -3.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 194.79M | 203.43% |
| Dec 31, 2025 | 64.20M | -28.73% |
| Dec 31, 2024 | 90.08M | 33.02% |
| Dec 29, 2023 | 67.72M | 9.04% |
| Dec 30, 2022 | 62.10M | -75.28% |
| Dec 31, 2021 | 251.21M | -20.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 15, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alpha Cognition | 198.80M |
| Protalix BioTherapeutics | 198.21M |
| Alector | 197.62M |
| Voyager Therapeutics | 197.58M |
| PepGen | 197.13M |
| Coherus Oncology | 195.90M |
| Humacyte | 193.65M |
| Precision BioSciences | 193.26M |